抑郁症的驱动因素在慢性中风后失言症中
medRxiv : the preprint server for health sciences
|November 28, 2024
概括
脑卒中后抑郁症在患有慢性左半球脑卒中和失语症的人群中很常见. 认知,社会和自我感知恢复显著预测抑郁症症状,表明干预的目标.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 康复医学 康复医学 康复医学
背景情况:
- 脑卒中后的抑郁症影响了三分之一的幸存者,降低了生活质量.
- 之前的研究往往忽视了慢性中风阶段和有显著失语症的个体.
- 这项研究调查了长期左半球中风幸存者的抑郁症.
研究的目的:
- 检查抑郁症症状与人口因素之间的关系.
- 为了识别与中风相关的残疾和与抑郁症相关的损伤.
- 为了探索抑郁症的预测因素,慢性中风幸存者与失言症.
主要方法:
- 横截面研究涉及92名脑卒中幸存者和70名对照.
- 使用贝克抑郁 inventory-II (BDI-II) 评估抑郁症.
- 评估的中风残疾 (中风影响量表3.0) 和损伤 (西方阿法西亚电池,NIH中风量表).
主要成果:
- 卒中幸存者在BDI-II上比对照高出3.4分.
- 年龄与抑郁症得分相反相关.
- 较低的认知功能,社会参与和自我感知恢复与较高的抑郁症相关.
结论:
- 认知和沟通缺陷,社会参与和自我感知的恢复是这一群体中抑郁症的关键相关因子.
- 抑郁症评估在中风后很长一段时间至关重要,即使是失言症.
- 研究结果表明,心理治疗的目标是缓解中风后的抑郁症.
相关概念视频
Depressive Disorders: Etiology
49
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
49
Depression: Overview
216
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
216
Antidepressant Drugs: MAOIs and Other Agents
194
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
194


